Avivagen Announces Closing of Private Placement and Conversion of Liabilities to Equity
ACCESSWIRE - Fri Apr 11, 3:12PM CDT
Ottawa, ON / ACCESSWIRE / April 11, 2014 / Avivagen Inc. (TSXV: VIV), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, announces the closing of its previously announced private placement.
Avivagen Announces Feed Conference Attendance in Bangkok, Thailand April 8 to 10
ACCESSWIRE - Mon Apr 07, 7:11AM CDT
Ottawa, ON / ACCESSWIRE / Apr 7, 2014 / - Avivagen Inc. (TSXV: VIV), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, announces that it will be attending important trade shows for the animal feed industries serving Asian markets.
Avivagen Announces Voting Results for the Election of its Directors
ACCESSWIRE - Fri Apr 04, 3:18PM CDT
Ottawa, ON / ACCESSWIRE / April 4 2014 / - Avivagen Inc. (TSXV: VIV), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, announces the results of shareholder voting for the election of its directors.
Avivagen Announces Poultry Trial Agreement with Chonbuk National University of Korea
ACCESSWIRE - Mon Mar 31, 7:05AM CDT
Ottawa, ON / ACCESSWIRE / March 31, 2014 / Avivagen Inc. (TSXV: VIV), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, announces an agreement with Chonbuk National University of the Republic of Korea (South Korea) to conduct a trial of OxC-beta for the prevention of a commercially important poultry disease.
Avivagen Announces Swine Trial Agreement with National Institute of Animal Sciences for Vietnam
ACCESSWIRE - Tue Mar 25, 7:21AM CDT
OTTAWA, ON / ACCESSWIRE / March 25, 2014 / Avivagen Inc. (TSXV: VIV), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, announces an agreement with the National Institute of Animal Sciences for Vietnam to conduct a trial of OxC-beta as a non-antibiotic growth promoter for swine.
Avivagen Announces CEO Update Letter
ACCESSWIRE - Mon Mar 17, 7:12AM CDT
Ottawa, ON / Accesswire / Mar 17 2014 / - Avivagen Inc. (TSXV:VIV), a wellness company developing and delivering products that support and enhance the health and quality of life of animals and the people who care for them, announces the release and website posting of a CEO update letter. In addition to reading the contents of the CEO update letter below, we encourage you to visit the Avivagen website to learn more about the company, at www.avivagen.com.
Avivagen Announces Nomination of New Director Mr. G.F. Kym Anthony Standing for Election
ACCESSWIRE - Fri Feb 28, 7:02AM CST
OTTAWA, ONTARIO / February 28, 2014 / ACCESSWIRE / Avivagen Inc. (TSXV:VIV), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, announces the nomination of a new Director, Mr. G.F. Kym Anthony, and the retirement of its current Chairman, Mr. Jacques Brault.